Trademark Search  /  NEUZATA

NEUZATA

● Live · Registered

U.S. federal trademark · Serial No. 98266438 · Reg. No. 74971691

Mark
NEUZATA
Status
Registered
Serial Number
98266438
Registration No.
74971691
Filing Date
November 12, 2023
Registration Date
April 21, 2024
Class(es)
Class 005

Owners

Abbisko Therapeutics Co., Ltd.
99 · Shanghai, CN
Abbisko Therapeutics Co., Ltd.
99 · Shanghai, CN
Abbisko Therapeutics Co., Ltd.
99 · Shanghai, CN

Goods & Services

Medicines for human purposes, namely, medicinal preparations for the treatment of cancer, immune system diseases and disorders and central nervous system diseases and disorders; Coated capsule medicines for prevention and treatment of human immune system diseases; Coated capsule anti-tumor medicines for prevention and treatment of human cancer; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparation for the treatment of central nervous system diseases and disorders; Chemico-pharmaceutical preparations, namely, chemical preparations for pharmaceutical or medical purposes, namely, for use in the treatment of cancer; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of cancer; Biological preparations for medical purposes, namely, biological preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer and the treatment of metastatic neoplastic diseases; Pharmaceutical preparations in the form of injections for tumor suppression; Pharmaceuticals for anti-tumor treatment; Pharmaceutical preparations for human biomedicine for the treatment of cancer and neurological diseases

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "NEUZATA" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.